Evidence map›Paper›PMID 30548534›Full record

ReviewWiley interdisciplinary reviews. Systems biology and medicine2019

Integrating molecular networks with genetic variant interpretation for precision medicine.

Emidio Capriotti, Kivilcim Ozturk, Hannah Carter

Abstract readReview
In one paragraph

Review in Wiley interdisciplinary reviews. Systems biology and medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Resources and tools for rare disease variant interpretation.Frontiers in molecular biosciences · 2023
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. CREB1ACS omega · 2021
    Article
  16. Analysis and Interpretation of the Impact of Missense Variants in Cancer.International journal of molecular sciences · 2021
    Review
  17. The DisGeNET cytoscape app: Exploring and visualizing disease genomics data.Computational and structural biotechnology journal · 2021
    Article
  18. Article
  19. Precision medicine - networks to the rescue.Current opinion in biotechnology · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Emidio CapriottiDepartment of Pharmacy and Biotechnology (FaBiT), University of Bologna, Bologna, Italy.
Kivilcim OzturkBioinformatics and Systems Biology Program, University of California, San Diego, La Jolla, California.
Hannah CarterDepartment of Medicine and Institute for Genomic Medicine, University of California, San Diego, La Jolla, California.

Funding

Network approaches to identify cancer drivers from high-dimensional tumor dataDP5OD017937 · OD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CARTER, HANNAH KATHRYN · 2013 to 2017
$1.9M
NIH HHS DP5 OD017937
6 · The paper itself

Abstract

More reliable and cheaper sequencing technologies have revealed the vast mutational landscapes characteristic of many phenotypes. The analysis of such genetic variants has led to successful identification of altered proteins underlying many Mendelian disorders. Nevertheless the simple one-variant one-phenotype model valid for many monogenic diseases does not capture the complexity of polygenic traits and disorders. Although experimental and computational approaches have improved detection of functionally deleterious variants and important interactions between gene products, the development of comprehensive models relating genotype and phenotypes remains a challenge in the field of genomic medicine. In this context, a new view of the pathologic state as significant perturbation of the network of interactions between biomolecules is crucial for the identification of biochemical pathways associated with complex phenotypes. Seminal studies in systems biology combined the analysis of genetic variation with protein-protein interaction networks to demonstrate that even as biological systems evolve to be robust to genetic variation, their topologies create disease vulnerabilities. More recent analyses model the impact of genetic variants as changes to the "wiring" of the interactome to better capture heterogeneity in genotype-phenotype relationships. These studies lay the foundation for using networks to predict variant effects at scale using machine-learning or algorithmic approaches. A wealth of databases and resources for the annotation of genotype-phenotype relationships have been developed to support developments in this area. This overview describes how study of the molecular interactome has generated insights linking the organization of biological systems to disease mechanism, and how this information can enable precision medicine. This article is categorized under: Translational, Genomic, and Systems Medicine > Translational Medicine Biological Mechanisms > Cell Signaling Models of Systems Properties and Processes > Mechanistic Models Analytical and Computational Methods > Computational Methods.

Indexed as

Genetic VariationPrecision MedicineDatabases, GeneticDiseaseGenetic Association StudiesHumansMachine LearningProtein Interaction MapsReceptor, trkBReceptor, trkBdisease mechanismgenetic diseasenetwork analysisvariant interpretation

Identifiers

PMID30548534
PMCPMC6450710

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.